Original Research

Establishing a Genetic Cancer Risk Assessment Clinic

Fed Pract. 2015 August;32(suppl 7):11S-145S

References

1. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996;77(11):2318-2324.

2. American College of Surgeons. Cancer Program Standards 2012: Ensuring Patient- Centered Care, v1.2.1. Chicago, IL: American College of Surgeons; 2012. https://www.facs.org/~/media/files/quality%20programs/cancer/coc/programstandards2012.ashx. Accessed July 6, 2015.

3. Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet. 2008;124(1):31-34.

4. Moreira L, Balaguer F, Lindor N, et al; EPICOLON Consortium. Identification of Lynch syndrome among patients with colorectal cancer. JAMA. 2012;308(15):1555-1565.

5. Bülow S, Faurschou Nielsen T, Bülow C, Bisgaard ML, Karlsen L, Moesgaard F. The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int J Colorect Dis. 1996;11(2):88-91.

6. Duncan PR, Lin JT. Ingredients for success: a familial cancer clinic in an oncology
practice setting. J Oncol Pract. 2011;7(1):39-42.

7. Grover S, Kastrinos F, Steyerberg EW, et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA. 2012;308(5):485-492.

8. Hampel H, de la Chapelle A. How do we approach the goal of identifying everybody with Lynch syndrome? Fam Cancer. 2013;12(2):313-317.

9. Duncan PR, Lin JT, Feddersen R. Prospective screening for Lynch syndrome (LS) in a cohort of colorectal cancer (CRC) surgical patients in a community hospital. J Clin Oncol. 2010;28(suppl; abstr 1535):15s.

10. Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum. 2014;57(8):1025-1048.

11. Domchek SM, Bradbury A, Garber JE, Offit K, Robson ME. Multiplex genetic testing for cancer susceptibility: out on a high wire without a net? J Clin Oncol. 2013;31(10):1267-1270.

	All men > 40 years old
	Men > 45 years old with a family history of prostate cancer
	Men > 30 years old who are BRCA1/2 carriers
	Black men > 40 years old

Establishing a Genetic Cancer Risk Assessment Clinic

References

Recommended Reading

Clinical Topics

Digital Edition

Multimedia

Conference Coverage

Establishing a Genetic Cancer Risk Assessment Clinic

References

Click here to read the digital edition.

Pages

Recommended Reading

Clinical Topics

Digital Edition

Multimedia

Conference Coverage